IntegraGen (FR0010908723 : ALINT - PEA-SME Eligible), a company specializing in the decoding of the human genome, today announced a global distribution agreement with Twist Bioscience for IntegraGen’s portfolio of genomic data analysis tools. The agreement includes distribution rights for SIRIUS™, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY™, an online biological interpretation tool for oncology intended to assist pathologists and oncologists transforming raw data obtained via high-throughput sequencing into a molecular report for translational and clinical research use.